Combination Chemotherapy in Treating Patients With Stage IV Locally Advanced or Metastatic Bladder Cancer

NCT00005086 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: cisplatin
DRUG: docetaxel
DRUG: gemcitabine hydrochloride
DRUG: methotrexate

Sponsor

University of Chicago

Collaborators

[object Object]